Table 1.
Inclusion criteria |
Subjects should understand the risks and benefits of the protocol |
Adults aged 21–50 years |
BMI between 30 and 40 kg/m2 |
Willingness to participate in the exercise-walking program, supervised by a trained exercise specialist |
Willingness to consume the prescribed study diet of ∼2000 kcal/day as outlined in the protocol (meals provided free of cost by the study sponsor) |
Written informed consent to participate in the trial |
Willingness to complete standard health history questionnaire before recruitment into the study |
Willingness to participate in five clinical visits (screening, baseline, 2, 4 and 8 weeks) |
Subjects should abstain from alcoholic products during the study |
If female: should be negative in pregnancy test if of child-bearing potential, and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device, etc. |
Exclusion criteria |
History of thyroid disease, cardiovascular disease, or diabetes |
History of allergy to spices and herbal products |
Body weight with BMI>40 |
Nonobese (BMI<30) |
Using other weight loss medications, as well as stimulants, laxatives, or diuretics taken solely for the purpose of weight loss |
Recent unexplained weight loss or gain |
Positive HIV test |
Undergone surgery before 30 days of screening or planning to undergo surgery within the study period |
History of hepatitis, pancreatitis, lactic acidosis, or hepatomegaly with steatosis |
History of motor weakness or peripheral sensory neuropathy |
Any evidence of organ dysfunction or any clinically significant deviation from normal that could impact subjects' well-being or clinical outcome |
BMI, body mass index.